Michael Mauro Discusses Therapy-Free CML Remission
17 Visualizações
• 07/29/23
0
0
Embutir
administrator
Assinantes
Michael Mauro, MD, hematologist and leader of the Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses stopping chronic myeloid leukemia (CML) treatment for therapy-free remission.
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários